David Johnston
Family Medicine · Bryson City, NCNPI 1750674800
Payments from drug & device makers
Across 558 payments — averaging $16.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- AstraZeneca$852
- GSK$775
- Lilly USA, LLC$651
- plus $3K from 34 others
What the payments were for
- Speaking & faculty fees$851%
- Food & beverage$9,24599%
- Education$340%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$9,364 in reported general payments places this provider in the 90th percentile of 3,444 family medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 300 | $429,339 |
| EliquisApixaban | 195 | $234,975 |
| MounjaroTirzepatide | 167 | $182,324 |
| JardianceEmpagliflozin | 84 | $127,545 |
| XareltoRivaroxaban | 94 | $118,496 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 94 | $99,620 |
| FarxigaDapagliflozin Propanediol | 83 | $93,221 |
| Tresiba Flextouch U-200Insulin Degludec | 75 | $67,959 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 73 | $63,012 |
| EntrestoSacubitril/Valsartan | 54 | $61,528 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 13 | $60,213 |
| LinzessLinaclotide | 57 | $56,805 |
| CompleraEmtricita/Rilpivirine/Tenof Df | 14 | $49,909 |
| RybelsusSemaglutide | 21 | $41,901 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $34,881 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,346 | $471,240321 claims |
| PfizerEliquis | $324 | $234,975195 claims |
| Lilly USA, LLCMounjaro, Trulicity | $651 | $204,951192 claims |
| Johnson & JohnsonXarelto, Complera | $163 | $168,405108 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $189 | $142,326116 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $775 | $140,707160 claims |
| AstraZenecaFarxiga, Symbicort, Breztri Aerosphere | $852 | $115,871139 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $202 | $63,01273 claims |
| AbbVieLinzess, Synthroid | $1,340 | $62,201111 claims |
| NovartisEntresto | $156 | $61,52854 claims |
| Astellas Pharma US IncMyrbetriq | $119 | $19,50919 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $1,003 | $16,89617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Bryson City
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- Christian MartinShelby$5.4M
- John EarlHickory$4.7M
- Patrick MorganteHavelock$4.6M
- Stephen JonesShelby$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.